Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

ATP-degrading ENPP1 is required for survival (or persistence) of long-lived plasma cells.

Wang H, Gonzalez-Garcia I, Traba J, Jain S, Conteh S, Shin DM, Qi C, Gao Y, Sun J, Kang S, Abbasi S, Naghashfar Z, Yoon J, DuBois W, Kovalchuk AL, Sack MN, Duffy P, Morse HC 3rd.

Sci Rep. 2017 Dec 19;7(1):17867. doi: 10.1038/s41598-017-18028-z.

2.

mTOR intersects antibody-inducing signals from TACI in marginal zone B cells.

Sintes J, Gentile M, Zhang S, Garcia-Carmona Y, Magri G, Cassis L, Segura-Garzón D, Ciociola A, Grasset EK, Bascones S, Comerma L, Pybus M, Lligé D, Puga I, Gutzeit C, He B, DuBois W, Crespo M, Pascual J, Mensa A, Aróstegui JI, Juan M, Yagüe J, Serrano S, Lloreta J, Meffre E, Hahne M, Cunningham-Rundles C, Mock BA, Cerutti A.

Nat Commun. 2017 Nov 13;8(1):1462. doi: 10.1038/s41467-017-01602-4.

3.

Myc Regulates Chromatin Decompaction and Nuclear Architecture during B Cell Activation.

Kieffer-Kwon KR, Nimura K, Rao SSP, Xu J, Jung S, Pekowska A, Dose M, Stevens E, Mathe E, Dong P, Huang SC, Ricci MA, Baranello L, Zheng Y, Tomassoni Ardori F, Resch W, Stavreva D, Nelson S, McAndrew M, Casellas A, Finn E, Gregory C, St Hilaire BG, Johnson SM, Dubois W, Cosma MP, Batchelor E, Levens D, Phair RD, Misteli T, Tessarollo L, Hager G, Lakadamyali M, Liu Z, Floer M, Shroff H, Aiden EL, Casellas R.

Mol Cell. 2017 Aug 17;67(4):566-578.e10. doi: 10.1016/j.molcel.2017.07.013. Epub 2017 Aug 10.

4.

cFOS-SOX9 Axis Reprograms Bone Marrow-Derived Mesenchymal Stem Cells into Chondroblastic Osteosarcoma.

He Y, Zhu W, Shin MH, Gary J, Liu C, Dubois W, Hoover SB, Jiang S, Marrogi E, Mock B, Simpson RM, Huang J.

Stem Cell Reports. 2017 Jun 6;8(6):1630-1644. doi: 10.1016/j.stemcr.2017.04.029. Epub 2017 May 25.

5.

Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation.

Simmons JK, Michalowski AM, Gamache BJ, DuBois W, Patel J, Zhang K, Gary J, Zhang S, Gaikwad S, Connors D, Watson N, Leon E, Chen JQ, Kuehl WM, Lee MP, Zingone A, Landgren O, Ordentlich P, Huang J, Mock BA.

Mol Cancer Ther. 2017 Sep;16(9):2008-2021. doi: 10.1158/1535-7163.MCT-17-0171. Epub 2017 May 18.

6.

XII Diabetes Myths Debunked.

Dubois W.

Diabetes Self Manag. 2017 Jan;34(1):38-40.

PMID:
29737655
7.

CAFETERIA SURVIVAL A FIELD GUIDE.

Dubois W.

Diabetes Self Manag. 2016 Sep;33(5):22-25. No abstract available.

PMID:
29737643
8.

MET signaling in keratinocytes activates EGFR and initiates squamous carcinogenesis.

Cataisson C, Michalowski AM, Shibuya K, Ryscavage A, Klosterman M, Wright L, Dubois W, Liu F, Zhuang A, Rodrigues KB, Hoover S, Dwyer J, Simpson MR, Merlino G, Yuspa SH.

Sci Signal. 2016 Jun 21;9(433):ra62. doi: 10.1126/scisignal.aaf5106.

9.

Coming Soon to a Pharmacy Near You.

Dubois W.

Diabetes Self Manag. 2016 May-Jun;33(3):88-91.

PMID:
27290782
10.

More Consumer Diabetes Products Using Technology to Get--and Stay--Connected.

Dubois W.

Diabetes Self Manag. 2016 Mar-Apr;33(2):36-8, 40, 42. No abstract available.

PMID:
27086399
11.

The symptomless condition.

Dubois W.

Diabetes Self Manag. 2015 Nov-Dec;32(6):88-91. No abstract available.

PMID:
26666057
12.

ALL IN A DAY'S WORK.

Dubois W.

Diabetes Self Manag. 2015 Mar-Apr;32(2):24-5, 29-30, 32 passim. No abstract available.

PMID:
26665832
13.

Fear of fat. A fresh look at an old enemy.

Dubois W.

Diabetes Self Manag. 2015 Sep-Oct;32(5):26-8. No abstract available.

PMID:
26521606
14.

Welcome to Diabetes.

Dubois W.

Diabetes Self Manag. 2015 Jul-Aug;32(4):72-5. No abstract available.

PMID:
26380400
15.

An Apela RNA-Containing Negative Feedback Loop Regulates p53-Mediated Apoptosis in Embryonic Stem Cells.

Li M, Gou H, Tripathi BK, Huang J, Jiang S, Dubois W, Waybright T, Lei M, Shi J, Zhou M, Huang J.

Cell Stem Cell. 2015 Jun 4;16(6):669-83. doi: 10.1016/j.stem.2015.04.002. Epub 2015 Apr 30.

16.

p53 loss increases the osteogenic differentiation of bone marrow stromal cells.

He Y, de Castro LF, Shin MH, Dubois W, Yang HH, Jiang S, Mishra PJ, Ren L, Gou H, Lal A, Khanna C, Merlino G, Lee M, Robey PG, Huang J.

Stem Cells. 2015 Apr;33(4):1304-19. doi: 10.1002/stem.1925.

17.

B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity.

Qian J, Wang Q, Dose M, Pruett N, Kieffer-Kwon KR, Resch W, Liang G, Tang Z, Mathé E, Benner C, Dubois W, Nelson S, Vian L, Oliveira TY, Jankovic M, Hakim O, Gazumyan A, Pavri R, Awasthi P, Song B, Liu G, Chen L, Zhu S, Feigenbaum L, Staudt L, Murre C, Ruan Y, Robbiani DF, Pan-Hammarström Q, Nussenzweig MC, Casellas R.

Cell. 2014 Dec 18;159(7):1524-37. doi: 10.1016/j.cell.2014.11.013. Epub 2014 Dec 4.

18.

Blood glucose self-monitoring. Part 3: smart monitoring.

Dubois W.

Diabetes Self Manag. 2014 Oct;31(5):14, 17-9. No abstract available.

PMID:
25322655
19.

Loss-of-function RNAi screens in breast cancer cells identify AURKB, PLK1, PIK3R1, MAPK12, PRKD2, and PTK6 as sensitizing targets of rapamycin activity.

Ou O, Huppi K, Chakka S, Gehlhaus K, Dubois W, Patel J, Chen J, Mackiewicz M, Jones TL, Pitt JJ, Martin SE, Goldsmith P, Simmons JK, Mock BA, Caplen NJ.

Cancer Lett. 2014 Nov 28;354(2):336-47. doi: 10.1016/j.canlet.2014.08.043. Epub 2014 Sep 1.

20.

Blood glucose self-monitoring. Part 2: monitoring technique.

Dubois W.

Diabetes Self Manag. 2014 Jul-Aug;31(4):66-9.

PMID:
25137834
21.

Blood glucose self-monitoring. Part I: the gear.

Dubois W.

Diabetes Self Manag. 2014 May-Jun;31(3):14, 16-9. No abstract available.

PMID:
24941502
22.

Everything you ever wanted to know about injecting insulin...but didn't know to ask.

Dubois W.

Diabetes Self Manag. 2013 Sep-Oct;30(5):37-8, 40-2. No abstract available.

PMID:
24224333
23.

Diabetes quiz. How much do you know about the HbA1c test?

Dubois W.

Diabetes Self Manag. 2013 Sep-Oct;30(5):35-6. No abstract available.

PMID:
24224332
24.

Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression.

Wu JJ, Liu J, Chen EB, Wang JJ, Cao L, Narayan N, Fergusson MM, Rovira II, Allen M, Springer DA, Lago CU, Zhang S, DuBois W, Ward T, deCabo R, Gavrilova O, Mock B, Finkel T.

Cell Rep. 2013 Sep 12;4(5):913-20. doi: 10.1016/j.celrep.2013.07.030. Epub 2013 Aug 29.

25.

Metformin: the unauthorized biography.

Dubois W.

Diabetes Self Manag. 2013 May-Jun;30(3):8-14. No abstract available.

PMID:
23951628
26.

A genome-wide map of CTCF multivalency redefines the CTCF code.

Nakahashi H, Kieffer Kwon KR, Resch W, Vian L, Dose M, Stavreva D, Hakim O, Pruett N, Nelson S, Yamane A, Qian J, Dubois W, Welsh S, Phair RD, Pugh BF, Lobanenkov V, Hager GL, Casellas R.

Cell Rep. 2013 May 30;3(5):1678-1689. doi: 10.1016/j.celrep.2013.04.024. Epub 2013 May 23.

27.

Unintended consequences. When good management efforts go wrong.

Dubois W.

Diabetes Self Manag. 2013 Mar-Apr;30(2):50-3. No abstract available.

PMID:
23614222
28.

Rap2b, a novel p53 target, regulates p53-mediated pro-survival function.

Zhang X, He Y, Lee KH, Dubois W, Li Z, Wu X, Kovalchuk A, Zhang W, Huang J.

Cell Cycle. 2013 Apr 15;12(8):1279-91. doi: 10.4161/cc.24364. Epub 2013 Mar 27.

29.

Diabetes quiz. How much do you know about winter woes?

Dubois W.

Diabetes Self Manag. 2013 Jan-Feb;30(1):45-6. No abstract available.

PMID:
23409446
30.

High blood glucose: what's behind the symptoms?

Dubois W.

Diabetes Self Manag. 2012 Sep-Oct;29(5):34-6, 38-40. No abstract available.

PMID:
23057176
31.

Oncogenic Myc translocations are independent of chromosomal location and orientation of the immunoglobulin heavy chain locus.

Spehalski E, Kovalchuk AL, Collins JT, Liang G, Dubois W, Morse HC 3rd, Ferguson DO, Casellas R, Dunnick WA.

Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13728-32. doi: 10.1073/pnas.1202882109. Epub 2012 Aug 6.

32.

Mouse model of endemic Burkitt translocations reveals the long-range boundaries of Ig-mediated oncogene deregulation.

Kovalchuk AL, Ansarah-Sobrinho C, Hakim O, Resch W, Tolarová H, Dubois W, Yamane A, Takizawa M, Klein I, Hager GL, Morse HC 3rd, Potter M, Nussenzweig MC, Casellas R.

Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):10972-7. doi: 10.1073/pnas.1200106109. Epub 2012 Jun 18.

33.

How much do you know about high and low blood glucose?

Dubois W.

Diabetes Self Manag. 2012 May-Jun;29(3):57-8. No abstract available.

PMID:
22685886
34.

How much do you know about ketones?

Dubois WL.

Diabetes Self Manag. 2012 Jan-Feb;29(1):34, 36. No abstract available.

PMID:
22479810
35.

Distinct regulatory mechanisms and functions for p53-activated and p53-repressed DNA damage response genes in embryonic stem cells.

Li M, He Y, Dubois W, Wu X, Shi J, Huang J.

Mol Cell. 2012 Apr 13;46(1):30-42. doi: 10.1016/j.molcel.2012.01.020. Epub 2012 Mar 1.

36.

Global gene expression profiling in mouse plasma cell tumor precursor and bystander cells reveals potential intervention targets for plasma cell neoplasia.

LeGrand J, Park ES, Wang H, Gupta S, Owens JD Jr, Nelson PJ, DuBois W, Bair T, Janz S, Mushinski JF.

Blood. 2012 Jan 26;119(4):1018-28. doi: 10.1182/blood-2011-06-363887. Epub 2011 Dec 6.

37.

mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells.

Smrz D, Kim MS, Zhang S, Mock BA, Smrzová S, DuBois W, Simakova O, Maric I, Wilson TM, Metcalfe DD, Gilfillan AM.

Blood. 2011 Dec 22;118(26):6803-13. doi: 10.1182/blood-2011-06-359984. Epub 2011 Nov 3.

38.

Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production.

Zhang S, Readinger JA, DuBois W, Janka-Junttila M, Robinson R, Pruitt M, Bliskovsky V, Wu JZ, Sakakibara K, Patel J, Parent CA, Tessarollo L, Schwartzberg PL, Mock BA.

Blood. 2011 Jan 27;117(4):1228-38. doi: 10.1182/blood-2010-05-287821. Epub 2010 Nov 15.

39.

Regulation of microRNA expression and abundance during lymphopoiesis.

Kuchen S, Resch W, Yamane A, Kuo N, Li Z, Chakraborty T, Wei L, Laurence A, Yasuda T, Peng S, Hu-Li J, Lu K, Dubois W, Kitamura Y, Charles N, Sun HW, Muljo S, Schwartzberg PL, Paul WE, O'Shea J, Rajewsky K, Casellas R.

Immunity. 2010 Jun 25;32(6):828-39. doi: 10.1016/j.immuni.2010.05.009. Epub 2010 Jun 3.

40.

IL-6 and MYC collaborate in plasma cell tumor formation in mice.

Rutsch S, Neppalli VT, Shin DM, DuBois W, Morse HC 3rd, Goldschmidt H, Janz S.

Blood. 2010 Mar 4;115(9):1746-54. doi: 10.1182/blood-2009-08-237941. Epub 2009 Dec 17.

41.

Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibility.

Zhang K, Kagan D, DuBois W, Robinson R, Bliskovsky V, Vass WC, Zhang S, Mock BA.

Blood. 2009 Oct 1;114(14):2952-60. doi: 10.1182/blood-2009-01-198812. Epub 2009 Aug 4.

42.

AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development.

Takizawa M, Tolarová H, Li Z, Dubois W, Lim S, Callen E, Franco S, Mosaico M, Feigenbaum L, Alt FW, Nussenzweig A, Potter M, Casellas R.

J Exp Med. 2008 Sep 1;205(9):1949-57. doi: 10.1084/jem.20081007. Epub 2008 Aug 4.

43.

A comparison of two combinations of xylazine-ketamine administered intramuscularly to alpacas and of reversal with tolazoline.

Prado TM, DuBois WR, Ko JC, Mandsager RE, Morgan GL.

Vet Anaesth Analg. 2008 May;35(3):201-7. doi: 10.1111/j.1467-2995.2007.00375.x. Epub 2008 Feb 18.

PMID:
18282257
44.

Transgenic expression of Bcl-xL or Bcl-2 by murine B cells enhances the in vivo antipolysaccharide, but not antiprotein, response to intact Streptococcus pneumoniae.

Chattopadhyay G, Khan AQ, Sen G, Colino J, DuBois W, Rubtsov A, Torres RM, Potter M, Snapper CM.

J Immunol. 2007 Dec 1;179(11):7523-34.

45.

AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements.

Kovalchuk AL, duBois W, Mushinski E, McNeil NE, Hirt C, Qi CF, Li Z, Janz S, Honjo T, Muramatsu M, Ried T, Behrens T, Potter M.

J Exp Med. 2007 Nov 26;204(12):2989-3001. Epub 2007 Nov 6.

46.

CDDO-Imidazolide inhibits growth and survival of c-Myc-induced mouse B cell and plasma cell neoplasms.

Han SS, Peng L, Chung ST, DuBois W, Maeng SH, Shaffer AL, Sporn MB, Janz S.

Mol Cancer. 2006 Jun 7;5:22.

47.

Insertion of Myc into Igh accelerates peritoneal plasmacytomas in mice.

Park SS, Shaffer AL, Kim JS, duBois W, Potter M, Staudt LM, Janz S.

Cancer Res. 2005 Sep 1;65(17):7644-52.

48.

Improving test ordering in primary care: the added value of a small-group quality improvement strategy compared with classic feedback only.

Verstappen WH, van der Weijden T, Dubois WI, Smeele I, Hermsen J, Tan FE, Grol RP.

Ann Fam Med. 2004 Nov-Dec;2(6):569-75.

49.

Comparing cost effects of two quality strategies to improve test ordering in primary care: a randomized trial.

Verstappen WH, van Merode F, Grimshaw J, Dubois WI, Grol RP, van der Weijden T.

Int J Qual Health Care. 2004 Oct;16(5):391-8.

PMID:
15375100
50.

Variation in test ordering behaviour of GPs: professional or context-related factors?

Verstappen WH, ter Riet G, Dubois WI, Winkens R, Grol RP, van der Weijden T.

Fam Pract. 2004 Aug;21(4):387-95.

PMID:
15249527

Supplemental Content

Loading ...
Support Center